In Fig. 5A, ERK1/2 gene expression was significantly upregulated in the BPH group compared to the control, while treatment with HCQ or FIN alone significantly reduced its expression, with the combination treatment showing the most pronounced decrease (p < 0.05). Here, MAPK3 is linked to benign prostatic hyperplasia.